BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15531549)

  • 1. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP.
    Plaisier M; Kapiteijn K; Koolwijk P; Fijten C; Hanemaaijer R; Grimbergen JM; Mulder-Stapel A; Quax PH; Helmerhorst FM; van Hinsbergh VW
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5828-36. PubMed ID: 15531549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-type matrix metalloproteinases and vascularization in human endometrium during the menstrual cycle.
    Plaisier M; Koolwijk P; Hanemaaijer R; Verwey RA; van der Weiden RM; Risse EK; Jungerius C; Helmerhorst FM; van Hinsbergh VW
    Mol Hum Reprod; 2006 Jan; 12(1):11-8. PubMed ID: 16415334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
    Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW
    Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).
    Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR
    J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury.
    Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K
    Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.
    Jadhav U; Chigurupati S; Lakka SS; Mohanam S
    Int J Oncol; 2004 Nov; 25(5):1407-14. PubMed ID: 15492832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
    Liu K; Olofsson JI; Wahlberg P; Ny T
    Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
    Ohnishi Y; Tajima S; Ishibashi A
    Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels.
    Koike T; Vernon RB; Hamner MA; Sadoun E; Reed MJ
    J Cell Biochem; 2002; 86(4):748-58. PubMed ID: 12210741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
    D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
    Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T; Masson R; Basset P; Blasi F; Talarico D
    Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.